Introduction {#S1}
============

The ATP-binding cassette (ABC) superfamily is a major class of nucleotide-binding proteins found in all domains of life^[@R1]^. It is comprised of nine families, ABCA through ABCI, according to the classification scheme approved by the Human Genome Organization (HUGO), and its members are involved in many biological processes^[@R2]--[@R5]^.

While some ABC proteins are soluble and involved in processes such as DNA repair and chromosome segregation^[@R6]^, many are ATP-dependent, integral membrane 'transporters', that move a diverse range of compounds across cellular membranes^[@R7]^. These transporters are critical for maintaining cellular homeostasis via processes such as drug and metabolite export, lipid trafficking and nutrient uptake (among others)^[@R8]^.

ABC transporters have a conserved core structure of two cytosolic nucleotide binding domains (NBDs) and two transmembrane domains (TMDs). The NBDs are found in all ABC proteins and contain the regions responsible for ATP-binding and hydrolysis. The TMDs are comprised of multiple (usually 6) hydrophobic membrane spanning segments.

Mutations in ABC transporter genes are implicated in numerous inherited human diseases (see comprehensive reviews^[@R4],[@R9]^). Overexpression of ABC transporters also plays a role in drug resistance of cancer cells and pathogenic microorganisms^[@R10],[@R11]^. The study of ABC transporters is therefore of great clinical interest. However, despite considerable research to date, there is still much to learn about their function and regulation.

One powerful approach for studying protein function is via generation of protein interaction maps ('interactomes'), which provide a broad-based look at the functional and regulatory associations within the cell. Therefore, to better understand ABC transporters, we set out to map the interactome of the members of this superfamily encoded within the genome of the budding yeast *Saccharomyces cerevisiae* using membrane yeast two-hybrid (MYTH) technology; a robust tool for studying interactions of full-length membrane proteins in their natural cellular environment^[@R12],[@R13]^. *S. cerevisiae* encodes 30 ABC proteins, spanning five of the nine recognized ABC families. Of these, 22 are membrane bound transporters, many homologous to disease-linked human ABC proteins, making *S. cerevisiae* an ideal model organism for studying ABC transporter regulation and function^[@R5],[@R14]^.

Herein, we describe the interactome mapping of all 19 non-mitochondrial ABC transporters encoded by the budding yeast genome. Our results reveal that ABC transporters physically associate with proteins involved in a variety of cellular processes, and provide novel insight into the cellular role and regulation of the members of this clinically relevant group of membrane transporters.

Results {#S2}
=======

Construction and Validation of MYTH Baits {#S3}
-----------------------------------------

Of the 22 ABC transporters in *S. cerevisiae* ([Table 1](#T1){ref-type="table"}), 19 are predicted to have cytosolic termini, a requirement for MYTH baits. The remaining 3 transporters, Atm1p, Mdl1p and Mdl2p, are localized to the inner mitochondrial membraneand were therefore omitted from the current study^[@R5]^.

We tagged all 19 non-mitochondrial transporters at their C-termini with the Cub-(YFP)-LexA-VP16 MYTH tag. Tagging was carried out endogenously (iMYTH approach) or, where the endogenously-tagged strains failed validation (see below), by cloning the target gene into the AMBV MYTH bait vector (tMYTH approach). Note that cloning of the *NFT1* gene required correction of a nonsense mutation present in several laboratory strains^[@R15]^ (see Online Methods and Supplementary Results, [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}).

To validate tagged bait strains we used two approaches, the NubGI test and fluorescence microscopy^[@R13]^. The NubGI test ensured that the baits were properly expressed and did not non-specifically self-activate. In this test, we transformed bait strains with both positive (NubI) and negative (NubG) interaction control preys. To be suitable for screening, a bait strain needed to grow on interaction selection media when transformed with NubI, but not NubG, control prey (see example in [Fig. 1a](#F1){ref-type="fig"}). We next used fluorescence microscopy on baits tagged with Cub-YFP-LexA-VP16, to ensure tagging did not disrupt proper subcellular localization, as shown for Pxa1p as an example ([Fig. 1b](#F1){ref-type="fig"}).

Of the 19 ABC transporters, 17 passed both validation tests. For the 2 remaining transporters, Pdr11p and Pdr18p, bait strains were identified which passed the NubGI test, however YFP-tagged transporter was not expressed at levels suitable for detection by fluorescence microscopy. Since neither transporter was mislocalized (rather their specific localization could not be determined due to insufficient signal strength), we deemed both suitable for further screening. Of the 19 ABC baits selected for further analysis, 12 were endogenously tagged (iMYTH) baits and 7 were ectopically expressed (tMYTH) baits. Complete validation results are provided in [Supplementary Figures 2 and 3](#SD1){ref-type="supplementary-material"}, with the exception of those for Ycf1p, which have been reported previously^[@R16]^. Note that we analyzed Aus1p bait strains under anaerobic growth conditions, which cause a strong induction of Aus1p protein levels ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). Also note that Ste6p displays vacuolar luminal fluorescence, as previously published, due to its rapid recycling from the plasma membrane; Ste6p can only be detected on the plasma membrane when endocytosis is blocked^[@R17],[@R18]^.

Finally, to ensure MYTH-tagging did not disrupt transporter function, we subjected a representative set of six baits, for which a suitable test condition could be identified, to transporter-specific phenotypic challenge. In all cases, bait strains grew comparably to wild-type, indicating normal transporter function ([Fig. 1c](#F1){ref-type="fig"}).

MYTH Screening and Bait Dependency Testing {#S4}
------------------------------------------

We carried out MYTH screening of ABC transporter baits using NubG-X cDNA and genomic prey libraries (where X is the DNA fragment expressing the prey) prepared from *S. cerevisiae*. Our initial results were assembled into a 'preliminary' interactome, which we further refined experimentally using the bait dependency test^[@R13]^ to help determine reproducibility and specificity of the interactions. All preys which passed this secondary testing were used in subsequent analysis and assembly of our final ABC transporter interactome (see Online Methods).

Our final dataset contained 285 unique interactions across 209 proteins ([Supplementary Dataset 1](#SD1){ref-type="supplementary-material"}). We found candidate interactors for all ABC transporter baits, except Pdr11p, which produced no screening results. Pdr11p could not be cloned for tMYTH screening, possibly due to toxicity of the overexpressed construct, and anaerobic conditions failed to significantly increase Pdr11p levels in the iMYTH strain ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). Pdr11p was found as an interacting prey, however, in screens using different ABC transporter baits and is therefore represented in the final interactome.

Validation by Orthogonal Assays {#S5}
-------------------------------

As a secondary validation of our results, we performed orthogonal testing using Bimolecular Fluorescence Complementation (BiFC)^[@R19]^ and co-immunoprecipitation (Co-IP) on a representative subset of interactions.

For BiFC, we endogenously tagged proteins at their N- or C-termini using the C-terminal half of YFP (VC) in yeast strain BY4742 (for ABC transporters) or the N-terminal half of YFP (VN) in yeast strain BY4741 (for interactors). Corresponding strains were mated, and we examined resultant diploids by fluorescence microscopy to identify cells producing YFP signal, indicating interaction of constructs (see example in [Fig. 1d](#F1){ref-type="fig"}). Of the 79 interactions tested, 44 (55.6%) produced a positive BiFC signal ([Supplementary Figs. 5 to 11](#SD1){ref-type="supplementary-material"}).

We subjected the 35 interaction pairs which could not be confirmed by BiFC to Co-IP analysis using endogenously expressed TAP (tandem affinity purification) tagged baits^[@R20]^ and plasmids expressing full-length, HA (Human influenza hemagglutinin) tagged prey proteins^[@R21]^. Of these, 20 interactions (57%) produced a positive result, 11 interactions (32%) produced a negative result and 4 (11%) could not be tested due to technical issues with strain generation ([Supplementary Figs. 12 and 13](#SD1){ref-type="supplementary-material"}). The results of these two assays have an overall confirmation rate of 81.0% ([Fig. 1e](#F1){ref-type="fig"}). Our failure to confirm a subset of the tested interactions may have resulted from altered expression and steric issues, since MYTH allows detection of both prey fragments and full-length preys, while our BiFC and Co-IP approaches use full-length preys exclusively. Overall, orthogonal testing confirms a strikingly high percentage of our MYTH interactions, providing excellent support for the quality of the ABC interactome.

Assembly of Integrated ABC Transporter Interactome {#S6}
--------------------------------------------------

We integrated all MYTH screening results with the previously reported ABC transporter physical interactions available in the BioGRID database^[@R22]^, unambiguously compiling 537 unique binary interactions across 366 proteins. We then assigned each protein a functional classification, based upon manual inspection of Gene Ontology (GO) annotation and functional information available in the Saccharomyces Genome Database^[@R23]^. This annotated, integrated interactomeis presented in [Figure 2](#F2){ref-type="fig"}. A variant of this interactome, showing protein conservation in humans and disease association is provided in [Supplementary Figure 14 and Supplementary Dataset 2](#SD1){ref-type="supplementary-material"}. An interactome showing only interactions identified in our MYTH screen is provided in [Supplementary Figure 15](#SD1){ref-type="supplementary-material"}.

Functional Analysis of ABC Transporter Interactome {#S7}
--------------------------------------------------

The integrated interactome contains 14 functional groupings of varying size ([Fig. 2](#F2){ref-type="fig"} and [Supplementary Fig. 16](#SD1){ref-type="supplementary-material"}). The largest group (26%) corresponds to transport and related processes, consistent with the role of ABC transporters in the trafficking of cellular substances. The next largest group (16%) is proteins of unknown function, followed by those involved in metabolic processes (15%). The significant number of proteins of unknown function is intriguing, and investigation into these interactions may provide insight into new areas of ABC transporter regulation and function. The large number of metabolic proteins may be consistent with a role for ABC transporters in metabolic regulation and 'quality control', via the redirection, sequestration or export of key metabolites, with physical interactions providing immediate access to potential substrates, or allowing direct regulatory cross-talk between metabolic pathway constituents and the transporters. The remaining functional groups range in size from 1 to 7%, covering a range of diverse processes.

The association of ABC transporters with proteins of such a broad functional range suggests that their involvement in cellular function is more complex than previously demonstrated. Follow-up studies should help unlock this complexity and further elucidate the cellular role of these proteins. To this end, we carried out preliminary investigation of two interesting associations observed in our interactome -- the physical interaction of ABC transporters with one another, and the interaction of ABC transporters with members of the zinc transport system.

Physical Interactions between ABC Transporters {#S8}
----------------------------------------------

Examination of the interactome reveals a tendency of ABC transporters to interact with one another ([Fig. 2](#F2){ref-type="fig"}). Our MYTH screen detected 6 novel physical associations between ABC transporters, and confirmed 3 previously reported interactions ([Fig. 3a](#F3){ref-type="fig"}). We successfully validated these interactions using BiFC, with the exception of Pdr11p-Pdr18p, which failed to produce a signal, and Pdr11p-Nft1p, which could not be tested due to a nonsense mutation in the *NFT1* gene ([Fig. 3b](#F3){ref-type="fig"}). We did not detect six previously reported interactions (Pdr12p-Yor1p, Pdr12p-Snq2p, P×a1p-P×a2p, Ybt1p-P×a1p, Snq2p-Snq2p and Yor1p-Yor1p), possibly due to steric effects resulting from MYTH tagging.

While half-transporters such as P×a1p and P×a2p associate to form full-size, functional ABC transporter molecules^[@R24]^, there has been little investigation into the significance of interactions between full-size ABC transporters, which may be is regulatory in nature. A recent study shows that deletion of the *PDR5*, *SNQ2* or *YOR1* genes produces compensatory activation of the remaining transporters, a result proposed to involve transcriptional changes^[@R25]^. Since we detected a clear, reciprocal physical interaction between Snq2p and Pdr5p ([Fig. 3 a + b](#F3){ref-type="fig"}), we investigated if this compensatory activation might also involve effects at the protein level.

To this end we used BY4741 strains carrying deletions of the non-mitochondrial ABC transporter genes, obtained from the yeast deletion collection^[@R26]^. To measure transporter activity, we plated strains onto media containing benomyl (Snq2p substrate), cycloheximide (Pdr5p substrate) or 2,3,5-triphenyltetrazolium chloride (Pdr5p substrate)^[@R27]^.

As previously reported^[@R25]^, strains plated onto benomyl media displayed modest resistance in a *yor1*Δ background, and significantly increased resistance in *pdr5*Δ single deletion and *pdr5*Δ *yor1*Δ double deletion backgrounds ([Supplementary Figs. 17 and 18](#SD1){ref-type="supplementary-material"}). This effect disappeared in *pdr5*Δ *snq2*Δ and *yor1*Δ *snq2*Δ double deletions, consistent with it resulting from Snq2p activation ([Supplementary Fig. 17](#SD1){ref-type="supplementary-material"}). Compensatory activation was not evident in other ABC transporter single deletions ([Supplementary Fig. 18](#SD1){ref-type="supplementary-material"}), although a strong, unexpected sensitivity to benomyl was observed in the *pdr18*Δ strain (in addition to the predicted sensitivity of the *snq2*Δ strain), suggesting a previously unreported functional relationship between Snq2p and Pdr18p ([Supplementary Figs. 17 and 18](#SD1){ref-type="supplementary-material"}).

Unfortunately, we were unable to detect compensatory activation of Pdr5p under our test conditions ([Supplementary Figs. 19, 20 and 21](#SD1){ref-type="supplementary-material"}), likely a consequence of differences in strain background and growth conditions compared with earlier work^[@R25]^. We therefore focused on investigating the Snq2p phenotype, first examining the role of transcriptional changes using a quantitative real time PCR approach to measure relative *SNQ2* transcript levels ([Fig. 3c](#F3){ref-type="fig"}). Although we detected a modest increase of ∼1.5 fold in our *pdr5*Δ *yor1*Δ strain, we failed to find a significant change in *SNQ2* transcript levels in other deletion strains. This result revealed that the compensatory activation of Snq2p in our strains was not correlated with transcript level, and therefore not primarily a result of transcriptional changes. We next compared levels of Snq2p protein in the single deletion strains to the levels in wild-type ([Fig. 3d](#F3){ref-type="fig"} and [Supplementary Fig. 22](#SD1){ref-type="supplementary-material"}). No substantial increase in Snq2p protein levels was apparent in either the *pdr5*Δ or *yor1*Δ strains. We did, however, see a decrease in Snq2p protein level in the *pdr18*Δ strain, consistent with the increased benomyl sensitivity observed in this background. Additionally, we observed no gross changes in the plasma membrane localization of Snq2p in the deletion strains ([Fig. 3e](#F3){ref-type="fig"}). These results suggest that, while the increased sensitivity to benomyl in the *pdr18*Δ deletion strain may be due to changes in protein level, the significant enhancement of Snq2p activity in the *pdr5*Δ and *yor1*Δ strains is not a consequence of changes in Snq2p expression or localization.

ABC Transporters Are Involved in Zinc Homeostasis {#S9}
-------------------------------------------------

Another interesting observation is the association of several ABC transporters with two major yeast zinc transport proteins, Zrc1p (a vacuolar zinc uptake transporter responsible for zinc storage and detoxification^[@R28]^) and Zrt1p (a plasma membrane-localized, high affinity zinc uptake transporter induced under conditions of zinc limitation^[@R29]^). These interactions are summarized in [Figure 4a](#F4){ref-type="fig"}.

Considering the vacuolar localization of Zrc1p, its association with three plasma membrane localized ABC transporters is intriguing. We successfully validated the interaction between Pdr10p and Zrc1p using BiFC, observing a punctate signal located mainly around the cellular periphery ([Fig 4b](#F4){ref-type="fig"}). This signal co-localized with CFP-tagged Cdc42p (which localizes to plasma, vacuolar and nuclear membranes, [Supplementary Fig. 23a](#SD1){ref-type="supplementary-material"}), while signal produced by mCherry-tagged Sec63p (which localizes to the endoplasmic reticulum), was more discretely separated ([Supplementary Fig. 23b](#SD1){ref-type="supplementary-material"}). This is consistent with the signal occurring in the plasma membrane rather than the cortical ER, although we also occasionally observed weak BiFC signal on the vacuolar membrane. Our results suggest that the Pdr10p-Zrc1p interaction occurs on the plasma membrane, with a small sub-population of (potentially irreversible) BiFC complex travelling to the vacuole, although the possibility of complex forming in the vacuole and moving to the plasma membrane cannot be definitively ruled out. Determining the exact nature and functional significance of this interaction will require further investigation.

We observed no signal when examining the interactions of Zrc1p with Pdr18p and Yol075cp by BiFC ([Supplementary Figs. 8 and 9](#SD1){ref-type="supplementary-material"}). Additionally, we could not test the interactions of ABC transporters with full-length Zrt1p using BiFC, due to the extracellular localization of both Zrt1p termini^[@R30]^. We were, however, able to confirm the Pdr18p-Zrc1p interaction and all three ABC transporter-Zrt1p interactions by co-immunoprecipitation ([Supplementary Fig. 13](#SD1){ref-type="supplementary-material"}). The Yol075cp-Zrc1p interaction was not successfully validated, possibly due to technical issues, although our data (see below) may implicate it in metal homeostasis.

To investigate the functional significance of these interactions, we compared the growth of Y7092 yeast cells deleted of these ABC transporters under conditions of zinc availability, limitation and shock ([Fig. 4c](#F4){ref-type="fig"}). Deletion strains under 'standard' zinc replete conditions grew largely the same as wild-type, except *pdr10*Δ cells which had reduced absorbance at saturation. However, since we observed this phenotype in other media, it is unlikely related to zinc stress, and was not considered further. Under 'starvation' conditions (in media depleted of zinc and related metals by EDTA) *pdr18*Δ cells displayed a significantly increased lag phase, while *yol075c*Δ cells had a modest reduction in absorbance at saturation, suggesting possible roles of these transporters in metal homeostasis. We also investigated conditions of 'zinc shock', when cells are grown in low zinc media and then moved directly into conditions of high zinc availability. In low zinc, cells maximize zinc uptake, primarily via increased expression of Zrt1p. Upon transfer to high zinc conditions, cells rapidly take up zinc in detrimental amounts. To compensate, Zrc1p, whose expression is increased under low zinc conditions, rapidly sequesters zinc in the vacuole, thereby maintaining a safe cytosolic zinc concentration^[@R29],[@R31]^. Strikingly, the *pdr15*Δ strain displayed a significant growth delay upon 2 mM zinc shock, while both *pdr5*Δ and *pdr18*Δ strains also showed modest sensitivity.

We decided to focus further investigation on Pdr5p, Pdr15p and Pdr18p, since the interactions of these proteins with Zrt1p or Zrc1p were confirmed by orthogonal assay, and the phenotypes of their corresponding deletions implicated them in zinc homeostasis.

We first examined Zrt1p and Zrc1p levels in Y7092 wild-type and deletion cells grown in zinc limited media, conditions identical to those experienced prior to zinc shock. Surprisingly, no change in protein level of either transporter occurred in deletion strains relative to wild-type ([Fig. 4d](#F4){ref-type="fig"} and [Supplementary Fig. 24](#SD1){ref-type="supplementary-material"}). Gross localization of both transporters was also unchanged ([Fig. 4e](#F4){ref-type="fig"}). When we examined zinc transport in these cells ([Supplementary Fig. 25](#SD1){ref-type="supplementary-material"}), however, we observed that the *pdr15*Δ strain had a significant increase in zinc uptake of ∼2.7 fold relative to wild-type, consistent with this strain\'s zinc shock sensitivity. This appeared to be Zrt1p-dependent, as the same increase was not evident in a *pdr15*Δ *zrt1*Δ double deletion. Interestingly, deletion of Zrt1p transporter alone did not lead to a reduction in zinc uptake, likely a result of compensatory activity of other zinc uptake systems, such as Fet4p and the low affinity zinc uptake transporter Zrt2p. Zinc uptake of the *pdr5*Δ and *pdr18*Δ cells was comparable to wild-type, indicating their modest sensitivity was not a result of greater zinc influx. Notably, however, *pdr5*Δ *zrt1*Δ and *pdr18*Δ *zrt1*Δ double deletions did experience significant decreases in zinc uptake, with levels ∼60% and 50% that of wild-type, respectively.

We also examined Zrt1p and Zrc1p levels during zinc replete growth, identical to the conditions experienced by cells in our starvation experiment prior to growth in metal-depleted media. While levels of Zrt1p and Zrc1p were unchanged in *pdr5*Δ and *pdr15*Δ cells, they were significantly reduced in *pdr18*Δ cells ([Fig. 4f](#F4){ref-type="fig"} and [Supplementary Fig. 24](#SD1){ref-type="supplementary-material"}. This is consistent with the growth delay of *pdr18*Δ upon transfer to zinc limited media, since lower levels of these transporters (particularly Zrt1p) would initially reduce the capacity of the cells to take up zinc.

Using quantitative real time PCR, we observed that the lower Zrt1p levels correlated with reduced *ZRT1* mRNA transcript, while the reduction of Zrc1p appeared to be independent of transcriptional changes ([Fig. 4g](#F4){ref-type="fig"}). This suggests that a physical interaction with Pdr18p may be important for Zrc1p stability.

Discussion {#S10}
==========

Considering the ubiquitous nature of ABC transporters, and their major role in human disease, obtaining a better understanding of their regulation and function is of great clinical importance. To this end, we used the MYTH technology to successfully map the protein interactome of all 19 non-mitochondrial ABC transporters in the budding yeast *S. cerevisiae*. Combining the results of this screen with previously reported ABC transporter interactions in the BioGRID database allowed us to produce a comprehensive, integrated interactome, providing a detailed and unprecedented look at the cellular network involving these proteins.

The large number of functionally diverse interactors in our network suggests that ABC transporters have a more general involvement in cellular processes than previously suspected. Consistent with this is the large number of interactors of unknown function, demonstrating there is still much we do not understand about this protein class. Examination of the identifiable functional groups, however, does suggest significant involvement in transport and metabolic processes. Additionally, over 50% of the interactions involve a prey with an identifiable human ortholog, and of these, approximately 40% are associated with human disease, suggesting that further study of our interactome should provide information relevant to human disease states.

One interesting observation in our interactome is the tendency of full-size ABC transporters to interact with one another. While some of these interactions have been previously reported, our MYTH screening detected a number of previously unreported physical associations. Though the functional significance of these interactions has not been well studied, we suspect that they may play a regulatory role.

For instance, it is reported that deletion of *PDR10* affects the activity of Pdr12p at the protein level, however the mechanism by which this occursisunknown^[@R32]^. Here we have shown that these two proteins physically interact, suggesting this association may be directly responsible for regulating Pdr12p activity. Such an interaction may be important in maintaining the stability and membrane microenvironment of Pdr12p, both of which were observed to be affected in an earlier study^[@R32]^. It is also known that deletion of the *PDR5* gene leads to an increase in the activity of Snq2p^[@R25]^, two transporters between which we detected a robust physical interaction. Our investigation failed to detect changes in Snq2p localization, protein level or transcript amount in a *pdr5*Δ deletion, suggesting that the physical interaction between the proteins may directly lead to repression of Snq2p activity. We also observed that deletion of the *PDR18* gene affects Snq2p activity, via a transcription-independent decrease in Snq2p protein level.

Together these results suggest that physical interactions between full-length transporters could serve as an important form of regulation and communication. Changes in the level of one transporter, for example in response to altered environmental conditions, would cause a shift in the binding equilibrium between transporters, acting as a means of rapidly altering transporter activity. While the full extent of such regulation is unknown, the detection of what appears to be a network of interconnected ABC transporter proteins suggests it may be fairly expansive. Consistent with this is our observation that Pdr18p, which is connected only indirectly to Snq2p through physical interactions with intermediate ABC transporters, appears to be important for the stability of Snq2p. Communication through such a network, however, may also involve factors other than direct physical interaction, such as alterations in membrane composition, a process in which Pdr18p and other ABC transporters have been implicated^[@R33]--[@R36]^. Further investigation will be necessary to validate and determine the exact nature of such a regulatory system.

Another interesting observation from our MYTH screen is the association between ABC transporters and the Zrc1/Zrt1p zinc transporters. Our experiments demonstrated the importance of *PDR5*, *PDR15* and *PDR18* for mounting a proper zinc shock response, although deletion of these genes was not associated with changes in the level or localization of Zrc1p or Zrt1p, which both play major roles in this response^[@R29],[@R31]^. Interestingly, however, cells deleted of *PDR15* experienced an apparent Zrt1p-dependent increase in zinc uptake, likely accounting for this strain\'s zinc shock sensitivity.

The source of the modest zinc shock sensitivity of the *pdr5*Δ and *pdr18Δ* deletions is less clear, and may reflect subtle effects on Zrc1p (which we found interacting with Pdr18p). A decrease in Zrc1p activity would cause an increased sensitivity to zinc shock, due to a reduced ability to sequester excess cytosolic zinc in the vacuole^[@R31]^. Such a reduction, and the consequent increase in cytosolic zinc concentration, might also be involved in the reduced uptake activity observed in the *pdr5Δ zrt1Δ* and *pdr18Δ zrt1Δ* double deletions, which are forced to rely on the lower affinity Zrt2p and Fet4p zinc transporters. Additional work should help determine the mechanisms involved and whether other zinc transporters play a role.

We also observed a significant drop in Zrt1p and Zrc1p levels in *pdr18*Δ cells grown under zinc replete conditions. The drop in Zrc1p level did not correlate with a transcriptional change, suggesting that loss of physical interaction with Pdr18p may decrease its stability. The drop in Zrt1p level did appear to result from reduced transcription, though this is likely a consequence of reduced Zrc1p activity. Lower Zrc1p activity would lead to increased cytosolic zinc, and a corresponding reduction in activity of the Zap1p transcription factor, responsible for activating the expression of Zrt1p^[@R37]^. The decreased level of these transporters is likely responsible for the delayed growth phenotype of *pdr18*Δ cells upon transfer from zinc-replete to zinc-limited conditions, possibly as a consequence of reduced vacuolar zinc stores (resulting from reduced Zrc1p activity during zinc replete growth) and/or reduced Zrt1p levels, whose activity is necessary for efficient uptake of zinc under conditions of zinc limitation^[@R29]^.

Intriguingly, the effects observed with Zrt1p and Zrc1p are similar to those observed between full-length ABC transporters. These regulatory effects are also reminiscent of the'atypical' role of the human ABC proteins Sur1 and Sur2, which serve as the regulatory components of ion channels^[@R38]^. It is tempting to speculate that ABC transporters may have a general role as functional regulators of membrane proteins, in addition to their known transport roles. Further study of the interactome should help determine if such regulation is a common occurrence and what regulatory mechanism is employed.

Our initial investigation of the integrated ABC transporter interactome has provided a number of novel insights into the cellular role of this important class of transport proteins. With the large number of other interactions still unexplored, further examination of the network promises to greatly increase our understanding ABC transporter function and regulation. Considering the high percentage of interactors with human orthologs, much of the information gained should also be directly applicable to higher organisms. We believe that the data presented here will serve as a comprehensive and powerful resource for further studies into this clinically relevant class of proteins, and be of great value in the development of novel therapeutics directed towards the treatment of diseases associated with ABC transporter dysfunction.

Online Methods {#S11}
==============

Construction of ABC Transporter MYTH Baits {#S12}
------------------------------------------

iMYTH and tMYTH baits were generated as described previously^[@R13]^. In brief, iMYTH baits were generated by integration of Cub-(YFP)-LexA-VP16 KanMX cassette at the 3′ end of the ABC transporter gene of interest. tMYTH baits were generated using a 'gap-repair' approach^[@R39]^ into the MYTH bait plasmid AMBV (Dualsystems Biotech). For cloning of full-length *NFT1* into AMBV4, two partially overlapping gene fragments, each correcting the nonsense mutation present in S288C strains, were amplified and used for cloning into AMBV4 plasmid (see [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). All baits were verified by PCR and sequencing. A list of primer sequences used for bait generation can be found in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}.

Bait Localization by Fluorescence Microscopy {#S13}
--------------------------------------------

Subcellular localization of ABC transporter baits fused to Cub-YFP-LexA-VP16 MYTH tag was carried out using fluorescence microscopy. For all ABC transporters, with the exception of AUS1, cells expressing the ABC baits were grown to mid-log phase in SD-Complete (iMYTH bait strains) or SD-Leu (tMYTH bait strains) liquid medium at 30°C. Cells expressing AUS1 baits were grown anaerobically on solid SD-Complete media at 30°C for 3 days, in a sealed jar depleted of oxygen using BD GasPak Plus pouches. Cells from mid-log phase cultures or solid media (AUS1 bait) were examined at 630× magnification (11 z slices captured, 0.3 μm step size) using a Leica DMI 6000 B microscope with YFP, Texas Red and differential interference contrast (DIC) filter sets. Image capture and processing was performed using the Volocity software package (PerkinElmer).

Bait Validation using NubGI Control Test {#S14}
----------------------------------------

Suitability of generated baits for use in MYTH screening was assessed using the NubGI Control Test as previously described^[@R13]^. In brief, bait strains were transformed with Ost1p-NubI (positive interaction control) or Ost1p-NubG (negative interaction control) and spotted onto interaction selection media (SD-WAH for iMYTH strains or SD-WLAH for tMYTH strains). Plates were grown at 30°C for 2-3 days before analysis. Assays for *AUS1* bait were done under anaerobic conditions to allow for proper induction of Aus1p.

Functionality Testing of Selected Baits {#S15}
---------------------------------------

WT, MYTH-tagged (bait) and deletion strains were grown on YPAD plates for 2-3 days until single colonies appeared. Individual colonies were then diluted into 150 μL of sterile ddH~2~0 and 10-fold serially diluted up to a maximal dilution of 10 000×, prior to spotting onto appropriate challenge media. Plates were grown at 30°C for 3-4 days prior to imaging.

MYTH Library Screening and Data Analysis {#S16}
----------------------------------------

Library screening was carried out as previously described^[@R13]^, using a high efficiency yeast transformation protocol and both NubG-X cDNA and yeast genomic libraries. The cDNA library had a complexity of 2.2×10^6^ independent clones and contained inserts ranging from 0.4 to 5 kb, with an average size of 0.7 kb (Dualsystems Biotech). The genomic library had an overall complexity of 4×10^7^ and contained fragments ranging between 0.5 and 2 kb in size. Selection and transfer of colonies to liquid media and additional selection plates was carried out using a QP Interactor robotics system (Genetix). Interacting prey constructs obtained via MYTH screening were sequenced and identified using both automated analysis, consisting of a combination of in-house software and BLAST analysis tools, and subsequent manual inspection of individual sequences and chromatograms in order to properly identify prey candidates and eliminate spurious sequences. The resulting refined list of interactions comprised our initial MYTH interactome. This interactome was then further refined experimentally using the Bait Dependency Test, in which preys were transformed back into the original bait strain, as well as into a strain expressing artificial control bait (a minimal construct consisting of the Matα signal sequence, the single-pass transmembrane domain of the human T-cell surface glycoprotein CD4 and the Cub-LexA-VP16 tag). Preys that activated the reporter system in the original bait strain but not in the artificial control bait strain were deemed specific and used in subsequent analysis and assembly of the final ABC transporter interactome.

Bimolecular Fluorescence Complementation (BiFC) Analysis {#S17}
--------------------------------------------------------

BiFC analyses were carried out essentially as previously described^[@R40]^. Briefly, selected ABC transporter genes were endogenously tagged^[@R41]^ in strain BY4742 at either their 5′ or 3′ end with sequence encoding the C-terminal ('VC') fragment of YFP Venus^[@R42]^, while interactor genes were endogenously tagged in strain BY4741 at their 5′ or 3′ end with sequence encoding the N-terminal ('VN') fragment of YFP Venus. BY4741 and BY4742 strains were mated and resultant diploids examined for YFP signal by fluorescence microscopy. Image acquisition and processing were performed using Slidebook software (3i), as previously described^[@R43]^. For strains with relatively weak BiFC signals, we repeated imaging using a spinning disk confocal microscope (UltraView VoX; PerkinElmer Life and Analytical Sciences, Waltham, MA) equipped with a 100× oil NA 1.4 Plan-Apo Nikon objective lens, the EM CCD ImagEM (Back-Thinned Electron Multiplier CCD Camera), and a solid state 514-nm diode laser. A single optical section was captured for 1 sec exposure using 20% laser power (sensitivity 171) for a BiFC assay. To determine the localization of VC-PDR10/VN-ZRC1 interaction, the BiFC signal was captured in the presence of markers directed to the plasma membrane (pRS415-P~MET~-CFP-Cdc42) and endoplasmic reticulum (Sec63-mCherry). Image capture and processing were performed using the Volocity software package (PerkinElmer) and Image J software.

Generation of Integrated ABC Transporter Interactome {#S18}
----------------------------------------------------

Yeast physical interactions were retrieved from BioGRID release 3.1.81^[@R22]^ and mapped onto our refined ABC gene list. Only interactions that contained at least one ABC gene were retained. By combining our novel interactions, we constructed an ABC interaction network containing 537 unique binary interactions among 366 proteins. Cytoscape was used to integrate and visualize the network^[@R44]^.

Gene Ontology analysis {#S19}
----------------------

GO∷TermFinder (v0.86) was deployed to carry out Gene Ontology (GO) annotation and evaluation^[@R45]^. Gene annotations were downloaded from SGD (as of November 23, 2011)^[@R23]^, while GO annotations were downloaded from the GO website (as of November 23, 2011)^[@R46]^.

Orthology mapping between yeast and human {#S20}
-----------------------------------------

To define a comprehensive orthology mapping table between yeast and human, we identified orthologous pairs using the clustered orthologous groups deposited in the InParanoid database (v7.0)^[@R47]^. For yeast genes without annotations in InParanoid, we manually checked their annotations in SGD^[@R23]^. Yeast *YOR1* and *PXA2* were found to be similar to human cystic fibrosis transmembrane receptor and ATP-binding cassette sub-family D member 1, and included in our orthology mapping table.

Compiling human disease-associated genes {#S21}
----------------------------------------

To gain a high-confidence disease-gene annotation, we adopted the disease annotations deposited in McKusick\'s Online Mendelian Inheritance in Man (OMIM) database^[@R48]^ and the 'morbid map' table was downloaded from OMIM website (October 20, 2011). Disease-gene annotations were mapped to the genes in our interaction network.

Drug Challenge Assays {#S22}
---------------------

WT and ABC deletion strains (BY4741 background) were grown on YPAD +/appropriate antibiotic selection for 2-3. Individual colonies were diluted into 150 μL of sterile ddH~2~O and 10-fold serially diluted up to a maximal dilution of 1000×, prior to spotting onto SD-Complete media containing drug. Plates were grown at 30°C for 3-4 days prior to imaging.

Cell Growth for Protein and RNA Isolation {#S23}
-----------------------------------------

WT and deletion cells (BY4741 or Y7092 backgrounds) were inoculated from single colonies into SD-Complete (Standard, Metal Replete or Metal Limited) and grown overnight at 30°C to saturation. Overnight culture was diluted into fresh media and grown at 30°C for 4-5 hours. Cells were pelleted and stored at -20°C pending processing.

For analysis of aerobic vs. anaerobic induction of Aus1p-Cub-LexA-VP16 and Pdr11p-Cub-LexA-VP16, cells were grown on solid YPAD media at 30°C for 3 days either aerobically, or anaerobically in a sealed jar depleted of oxygen using BD GasPak Plus pouches. Cells were transferred from plates to microfuge tubes, rinsed briefly with SD-Complete media and stored at -20°C pending processing.

RNA Isolation and Quantitative Real-Time PCR Analysis {#S24}
-----------------------------------------------------

RNA was isolated from cells using the Masterpure Yeast RNA Purification Kit (Epicentre). cDNA synthesis was performed using Superscript II Reverse Transcriptase (Invitrogen). Quantitative real-time PCR amplification was performed using the Dynamo Flash SYBR Green qPCR Kit (Thermo Scientific) in a Light Cycler 480 II qPCR Machine (Roche) with the following amplification parameters: pre-incubation at 95°C for 7 min and 45 cycles of denaturation at 95°C for 10 seconds, annealing at 50°C for 35 seconds and extension at 72°C for 35 seconds. Primers used are listed in [Supplementary Table 2](#SD1){ref-type="supplementary-material"}. *ZRT1*, *ZRC1* and *SNQ2* transcript levels were expressed relative to levels of *ACT1* housekeeping gene mRNA.

Protein Isolation and Western Blotting {#S25}
--------------------------------------

Cells were resuspended in 500 μL 0.2M sodium hydroxide containing 0.2% β-mercaptoethanol and incubated on ice for 10 minutes. Proteins were precipitated by addition of 50 μL of 50% trichloroacetic acid, followed by a 10 minute incubation on ice. Precipitate was pelleted by centrifugation (18000 × g for 10 minutes at 4°C), resuspended in 50 μL 2× Sample Buffer (60 mM Tris, pH 6.8, 3% SDS, 10% glycerol) and protein concentration was determined using the Bio-Rad Protein Assay. Protein was resolved by SDS-PAGE using 10% gels and transferred to nitrocellulose membrane. MYTH-tagged proteins were detected using rabbit α-VP16 (Sigma) primary antibody and anti-rabbit IgG linked to horseradish-peroxidase (Cedarlane) as secondary antibody. Hexokinase was detected using α-hexokinase antibody coupled to horseradish peroxidase (Rockland Immunochemicals).

Co-immunoprecipitation Experiments {#S26}
----------------------------------

Selected interaction test pairs were confirmed using endogenously expressed TAP (tandem affinity purification) tagged bait^[@R20]^ and inducible, overexpressed, full-length, HA (Human influenza hemagglutinin) tagged protein^[@R21]^ as prey. Plasmid overproducing the HA tagged protein was transformed into the TAP-tagged bait strain background. Positive transformants were selected on SD medium lacking uracil and successively grown at 30°C in the same liquid medium with 2% sucrose as carbon source. After sub-culturing and 4 hrs induction with yeast peptone and 2% galactose, cells were pelleted by high-speed centrifugation (4,000 × g for 20 min), resuspended in appropriate lysis buffer, and processed as described previously^[@R49]^. Immunoprecipitated samples were run on a 10% SDS-PAGE gel, transferred onto nitrocellulose membrane and probed with rabbit anti-HA polyclonal antisera (Pierce).

Tecan Growth Experiments {#S27}
------------------------

Overnight culture of WT and deletion strains (Y7092 background) grown in either 'Metal Replete' (Standard and Starvation conditions) or 'Metal Limited' (Shock condition) SD-Complete medium was diluted into fresh medium to an OD~600~ =∼ 0.15 and grown at 30°C for 4 to 5 hours. Cells were diluted to an OD~600~ =∼ 0.0625 in 'Metal Limited' medium and 95 μL volumes were transferred to the wells of a sterile 96-well plate (Greiner 655 180). For 'Standard' and 'Shock' conditions 5 μL of sterile 40 mM zinc chloride solution was added, to a final concentration of 2 mM zinc. For 'Starvation' conditions 5 μL sterile ddH~2~O was added. Plates were transferred to a Tecan GENios plate-reader where growth was monitored by measurement of OD~595~ every 15 minutes for 50 hours. GraphPad Prism 6 was used for data analysis.

Zinc Transport Assays {#S28}
---------------------

WT and deletion cells (Y7092 background) were grown to exponential phase in 'Metal Limited' SD-Complete medium and harvested. Pellets were washed three times and resuspended in fresh 'Metal Limited' SD-Complete media supplemented with ^65^Zn and incubated for 5 minutes. Cells were collected on glass fiber filters and washed with 10 mL ice-cold SSW (1 mM EDTA, 20 mM sodium citrate pH 4.2). Cell-associated radioactivity was measured by scintillation counter and reported as cpm. All results are normalized to WT.

Media Recipes {#S29}
-------------

Media was prepared as previously described in detail^[@R13]^. Briefly, YPAD medium was made by dissolving 10g Yeast Extract, 20g Peptone, 20g D-Glucose, 40 mg Adenine Sulfate Dihydrate and 20g Agar (only for solid media) in a total volume of 1L ddH~2~O, and autoclaving. 2× YPAD was made in an identical manner but contained 20g Yeast extract, 40 g Peptone, 40g D-Glucose, 40 mg Adenine Sulfate Dihydrate and 20g Agar (only for solid media). SD-Complete and various drop-out media were made by dissolving 6.7g Yeast Nitrogen Base, 20 D-Glucose and 20g of Agar (only for solid media) in 900 mL of ddH~2~O followed by addition of appropriate 10× Nucleotide/Amino Acid solution (i.e. lacking whichever amino acids or nucleotides necessary for generation of the desired selective media) and autoclaving. 'Metal Replete' SD-Complete media was identical to SD-Complete media, but supplemented with 20 mM Sodium Citrate and adjusted to pH 4.2. 'Metal Limited' SD-Complete media was identical to 'Metal Replete' SD-Complete media, but contained 1 mM EDTA, pH 8.0. Oleic Acid (YNO) medium was made by dissolving 6.7 g Yeast Nitrogen Base and 20g of Agar in a total volume of 1L ddH~2~O supplemented with 10 mL BRIJ-35 (30% aqueous, Calbiochem), 1 mL Oleic Acid (\>99%, Nu-Chek Prep Inc), 30 mL Glycerol and 100 mL 10× Nucleotide/Amino Acid solution (complete), followed by autoclaving. Additional antibiotics, drugs etc. were added to media where necessary at desired concentrations. 10× Nucleotide/Amino Acid solution was made by dissolving 400 mg Adenine Sulfate Dihydrate, 200 mg Arginine Hydrochloride, 200 mg Histidine Monohydrochloride, 300 mg Isoleucine, 1000 mg Leucine, 300 mg Lysine Hydrochloride, 1500 mg Methionine, 500 mg Phenylalanine, 2000 mg Threonine, 400 mg Tryptophan, 300 mg Tyrosine, 200 mg Uracil and 1500 mg Valine in a total volume of 1 L of ddH~2~O and autoclaving. Unless otherwise indicated above, all components used in media preparation were obtained from BioShop Inc.
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![Overview of ABC transporters in *Saccharomyces cerevisiae* and validation of MYTH-tagged baits. (a) NubGI test of MYTH reporter strain expressing endogenously tagged Snq2p-Cub-LexA-VP16. The strain displays growth on interaction selection media only in the presence of the NubI-tagged positive interaction control prey, but not in the presence of the NubG-tagged negative interaction control prey. Scale bar is 10 mm. (b) Fluorescence microscopy images showing proper peroxisomal localization of P×a1p-Cub-YFP-LexA-VP16 expressed from MYTH reporter strain. P×a1 signal (yellow, YFP Channel) co-localizes with peroxisomal membrane-targeted control protein (red, RFP Channel). Scale bar is 6 μm. (c) Phenotypic challenge assay demonstrating normal function of MYTH-tagged ABC transporters. In all cases, strains expressing MYTH tagged ABC transporters display growth similar to that of the WT strain rather than to the reduced growth of strains carrying a deletion of the corresponding ABC transporter gene. TTZ = 2,3,5-Triphenyltetrazolium chloride. Scale bar is 15 mm.(d) Examples of BiFC images obtained for two of the interactions validated using BiFC. Scale bar is 5 μm. (e) Summary of the number of interactions tested by orthogonal assay which were positively confirmed by BiFC or Co-IP vs. the number of interactions which could not be confirmed.](nihms492181f1){#F1}

![Integrated ABC transporter interactome. Novel interactions identified by MYTH screening (red lines) are shown alongside interactions previously reported in the BioGRID database (yellow lines). Previously reported interactions confirmed by MYTH are also shown, as nodes connected by blue lines. Individual nodes are coloured according to functional classification and are assigned a shape based on whether they are bait/prey and localized to the membrane or soluble fraction, as described in the legend.](nihms492181f2){#F2}

![Investigation of interactions between full-length ABC transporters. (a) Interactions between full-length transporters detected in MYTH screening. Nodes connected by 'green' lines indicate interactions reported previously. (b) BiFC analysis of interactions between full-length ABC transporters detects clear signal for all interactor pairs, except Pdr11p-Pdr18p. Scale bar is 5 μm. Images marked with a '\*' were obtained via confocal microscopy as described in the Online Methods. (c) *SNQ2* transcript level in BY4741 WT and ABC deletion strains as determined using qPCR. Values represent the average of three biological replicates (n=3) and are expressed relative to WT. Error bars indicate standard deviation. The *pdr5*Δ*yor1*Δ double deletion (marked with an '\*\*') is the only strain with a significantly different level of SNQ2 transcript relative to WT (two-tailed t-test, p-value = 4.5×10^−5^). (d) Western blot analysis showing relative levels of Snq2p in BY4741 WT, *pdr5*Δ, *yor1*Δ and *pdr18*Δ strains. Hexokinase levels verify equal loading. Numbers below blot indicate ratio of Snq2p to Hexokinase, normalized to levels in WT strain. (e) Fluorescence microscopy visualization of Snq2p-CYT localization in BY4741 WT and ABC deletion strains. Snq2p-CYT displays identical peripheral localization in all strains, consistent with its predicted plasma membrane localization. Scale bar is 8 μm.](nihms492181f3){#F3}

![Investigating role of ABC transporters in zinc homeostasis. (a) Interactions between ABC transporters and the zinc transporters Zrc1p and Zrt1p. (b) BiFC signal observed for the Pdr10p-Zrc1p interaction pair. Scale bar is 5 μm. Image obtained using confocal microscopy as described in the Online Methods. (c) Growth of Y7092 WT and ABC deletion strains under standard, metal starvation and zinc shock conditions. (d) Western blot analysis of Zrt1p and Zrc1p levels in Y7092 WT and deletion strains grown under conditions of zinc limitation. Hexokinase levels verify equal loading. (e) Fluorescence microscopy analysis of localization of Zrt1p and Zrc1p inY7092 WT and deletion strains grown under conditions of zinc limitation. Scale bar is 6 μm. (f) Western blot analysis of Zrt1p and Zrc1p levels in Y7092 WT and deletion strains grown under zinc-replete conditions. Hexokinase levels verify equal loading.(g) *ZRT1* and *ZRC1* transcript levels in Y7092 WT and *pdr18*Δ deletion strains as determined using qPCR. Values represent the average of three biological replicates (n=3) and are expressed relative to WT. Error bars indicate standard deviation. Results show a significant reduction (two-tailed t-test, p-value = 7.9×10^−4^) of *ZRT1* transcript in *pdr18*Δ cells relative to WT, but no change in *ZRC1* transcript levels.](nihms492181f4){#F4}

###### *Saccharomyces cerevisiae* ABC Transporters

  ABC Transporter Family   ABC Transporter Name   Subcellular Localization
  ------------------------ ---------------------- --------------------------
  ABCB                     Atm1p                  Mitochondria
  Mdl1p                    Mitochondria           
  Mdl2p                    Mitochondria           
  Ste6p                    Plasma Membrane        
  ABCC                     Bpt1p                  Vacuole
  Nft1p                    Vacuole                
  Vmr1p                    Vacuole                
  Ybt1p                    Vacuole                
  Ycf1p                    Vacuole                
  Yor1p                    Plasma Membrane        
  ABCD                     Pxa1p                  Peroxisome
  Pxa2p                    Peroxisome             
  ABCG                     Adp1p                  Vacuole
  Aus1p                    Plasma Membrane        
  Snq2p                    Plasma Membrane        
  Pdr5p                    Plasma Membrane        
  Pdr10p                   Plasma Membrane        
  Pdr11p                   Plasma Membrane        
  Pdr12p                   Plasma Membrane        
  Pdr15p                   Plasma Membrane        
  Pdr18p                   Plasma Membrane        
  Yol075cp                 Plasma Membrane        
